MultiPark: Multidisciplinary research focused on Parkinson´s disease

Research output

Research output per year 2010 2010 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

• 3169 Article
• 258 Review article
• 192 Doctoral Thesis (compilation)
• 117 Abstract
• 495 More
  • 100 Book chapter
  • 98 Debate/Note/Editorial
  • 96 Published meeting abstract
  • 47 Paper in conference proceeding
  • 38 Poster
  • 36 Letter
  • 17 Preprint (in preprint archive)
  • 13 Specialist publication article
  • 7 Anthology (editor)
  • 6 Report
  • 6 Paper, not in proceeding
  • 5 Foreword/postscript
  • 4 Book
  • 4 Conference proceeding (editor)
  • 4 Review (Book/Film/Exhibition/etc.)
  • 4 Working paper
  • 3 Entry for encyclopedia/dictionary
  • 3 Special Issue (editor)
  • 1 Other
  • 1 Newspaper article
  • 1 Doctoral Thesis (monograph)
  • 1 Licentiate Thesis

Research output per year

Research output per year

Search results

• 2025

  Para athlete concussion care following the Amsterdam 2022 International Consensus Statement on Concussion in Sport: an urgent need for inclusivity within concussion research

  Weiler, R., Dalton, K., Guenther, A., Mitchell, K., Van de Vliet, P., Babul, S., Blauwet, C., Clarke, D., Dea, J., Derman, W., Emery, C., Fagher, K., Gouttebarge, V., Haider, M. N., Hunt, T., Lee, K., Lexell, J., Moran, R. N., Pilon, F. & Prince, F. & 5 others, Runciman, P., Smetana, R., Verhagen, E., Webborn, N. & Ahmed, O. H., 2025, In: British Journal of Sports Medicine. 59, 1, p. 5-7

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Concussion 100%
  • Neuromuscular 5%
• 2024

  A clinical perspective on the revised criteria for diagnosis and staging of Alzheimer's disease

  Hansson, O. & Jack, C. R., 2024 Aug, In: Nature Aging. 4, 8, p. 1029-1031

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

• Disentangling genetic risks for development and progression of Alzheimer’s disease

  Mattsson-Carlgren, N., 2024 Aug, In: Brain. 147, 8, p. 2604-2606 3 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

• Revised criteria for the diagnosis and staging of Alzheimer’s disease

  Jack, C. R., Andrews, S. J., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., Molinuevo, J. L., Okonkwo, O. C., Pani, L., Rafii, M. S., Scheltens, P., Siemers, E., Snyder, H. M., Sperling, R., Teunissen, C. E. & Carrillo, M. C., 2024 Aug, In: Nature Medicine. 30, 8, p. 2121-2124 4 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Amyloid Plaque 100%

• Five biomarkers from one cerebrospinal fluid sample to stage Alzheimer’s disease

  Salvadó, G. & Hansson, O., 2024 May, In: Nature Aging. 4, 5, p. 623-624 2 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Biological Marker 100%
  • Cerebrospinal Fluid 100%
  • Alzheimer's Disease 100%
  • Tau 50%
  • Clinical Trial 50%

• Unraveling the brain's response to hypoglycemia: Neurovascular coupling

  Duarte, J. M. & Schwaninger, M., 2024 Feb, In: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 44, 2, p. 313-314 2 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

  • Brain 100%
  • Hypoglycemia 100%
  • Functional Magnetic Resonance Imaging 33%

• A Useful Map With Some Blind Spots Still: Neurofilament Light Protein Differentiating Behavioral Variant Frontotemporal Dementia From Psychiatric Disorders

  Eratne, D. & Santillo, A. F., 2024, In: American Journal of Geriatric Psychiatry. 32, 8, p. 1002-1003

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

• Fluid Biomarker Changes After Amyloid-β–Targeting Drugs

  Ossenkoppele, R. & Teunissen, C. E., 2024, In: JAMA Neurology. 81, 6, p. 579-581 3 p.

  Research output: Contribution to journal › Debate/Note/Editorial
• 2023

  APOE Genotype in the Era of Disease-Modifying Treatment with Monoclonal Antibodies Against Amyloid-β

  Ossenkoppele, R. & Van Der Flier, W. M., 2023 Dec, In: JAMA Neurology. 80, 12, p. 1269-1271 3 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

• Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?

  Björkqvist, M., 2023 Dec, In: EBioMedicine. 98, 104882.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

• Join us on an amazing journey towards next-generation treatments for CNS disorders: Launch of Neuroprotection, a new high-quality journal in translational neuroscience

  Ji, X., Walczak, P., van Beusekom, H. M. M., Casas, A. I., Clarkson, A., Farr, T., Jolkkonen, J., Liang, Y., Modo, M. M., Rosado-de-Castro, P. H., Ruscher, K., Wang, Y. J., Wu, H., Zille, M., Li, S. & Boltze, J., 2023 Sept, In: Neuroprotection. 1, 1, p. 1-4 4 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

• Reprogramming Stars #13: Establishing Connections with Cellular Reprogramming–An Interview with Dr. Daniella Rylander Ottosson

  Ottosson, D. R. & Pereira, C. F., 2023 Aug, In: Cellular Reprogramming. 25, 4, p. 130-135 6 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

• Expanding on Research in Para Sport and Paralympic Sport

  Lexell, J. & Frontera, W. R., 2023 Apr 1, In: American Journal of Physical Medicine and Rehabilitation. 102, 4, p. 364 1 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

• Author Response: Association Between Dietary Habits in Midlife With Dementia Incidence Over a 20-Year Period

  Glans, I., 2023 Mar 21, In: Neurology. 100, 12, p. 595 1 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

• Did early studies of human traumatic brain injury overlook concomitant oligodendrocyte pathology in injured white matter tracts? A comment on “Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein”

  Marklund, N., 2023, In: Brain Pathology. 33, 6

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

• Editorial: Ultrasound micromanipulations and ocean acoustics: from human cells to marine structures

  Gong, Z., Cai, F., Li, W. & Baasch, T., 2023, In: Frontiers in Physics. 11, 1237899.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

• Editorial: Obesity and diabetes: implications for brain-immunometabolism, volume II

  Gaspar, J. M., Latini, A. & Duarte, J. M. N., 2023, In: Frontiers in Neuroscience. 17, 1244064.

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

• The emerging era of staging Alzheimer’s disease pathology using plasma biomarkers

  Mattsson-Carlgren, N. & Palmqvist, S., 2023, In: Brain. 146, 5, p. 1740-1742 3 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access
• 2022

  'Heading' in the right direction: Concussions reported at the Tokyo 2020 Paralympic Games

  Runciman, P., Blauwet, C., Kissick, J., Lexell, J., Schwellnus, M., Webborn, N. & Derman, W., 2022 Dec 13, In: British journal of sports medicine. 57, 1, p. 2-3 2 p.

  Research output: Contribution to journal › Debate/Note/Editorial

• A biomarker profile of elevated CSF p-tau with normal tau PET is associated with increased tau accumulation rates on PET in early Alzheimer’s disease

  Groot, C., Smith, R., Stomrud, E., Binette, A. P., Leuzy, A., Wuestefeld, A., Wisse, L. E. M., Palmqvist, S., Janelidze, S., Strandberg, O., Ossenkoppele, R. & Hansson, O., 2022 Dec, In: Alzheimer's and Dementia. 18, S1, e065666.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Alzheimer's Disease 100%
  • Positron Emission Tomography 100%
  • Amyloid 12%
  • Cognition 12%
  • Mild Cognitive Impairment 12%

• Age-related tau-PET uptake and its downstream effects extend beyond the medial temporal lobe in cognitively normal older adults

  Wuestefeld, A., Berron, D., Binette, A. P., van Westen, D., Stomrud, E., Mattsson-Carlgren, N., Strandberg, O., Smith, R., Palmqvist, S., Glenn, T., Hansson, O. & Wisse, L. E. M., 2022 Dec, In: Alzheimer's and Dementia. 18, S1, e067081.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Positron Emission Tomography 100%
  • Temporal Lobe 100%
  • Cognition 33%
  • Magnetic Resonance Imaging 6%
  • Neurodegeneration 6%

• Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer

  Binette, A. P., Franzmeier, N., Spotorno, N., Ewers, M., Brendel, M., Biel, D., Strandberg, O., Janelidze, S., Palmqvist, S., Mattsson-Carlgren, N., Smith, R., Stomrud, E., Ossenkoppele, R. & Hansson, O., 2022 Dec, In: Alzheimer's and Dementia. 18, S1, e065080.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Emissions 100%
  • Tomography 100%
  • Aggregate 100%
  • Positron 100%
  • Positron Emission Tomography 100%

• CenTauR_z: A standardized quantification of tau PET scans

  Dore, V., Bullich, S., Bohorquez, S. S., Leuzy, A., Shimada, H., Rowe, C., Bourgeat, P., Lopresti, B. J., Huang, K., Krishnadas, N., Fripp, J., Takado, Y., Stephens, A. W., Weimer, R., Higuchi, M., Hansson, O. & Villemagne, V. L., 2022 Dec, In: Alzheimer's and Dementia. 18, S1, e061177.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Tau 100%
  • Radioactive Tracer 90%
  • Positron Emission Tomography 50%
  • In Vivo 16%
  • Cerebellar Cortex 16%

• Earlier Alzheimer's disease onset is associated with a shift of tau pathology towards brain hubs which facilitates tau spreading

  Franzmeier, N., Ewers, M., Brendel, M., Biel, D., Ossenkoppele, R., Hager, P., Steward, A., Dewenter, A., Rubinski, A., Buerger, K., Janowitz, D., Binette, A. P., Smith, R., Strandberg, O., Mattsson-Carlgren, N., Dichgans, M., Frontzkowski, L. & Hansson, O., 2022 Dec, In: Alzheimer's and Dementia. 18, S1, e067084.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Brain 100%
  • Alzheimer's Disease 100%
  • Protocerebrum 100%
  • Positron Emission Tomography 58%
  • Functional Magnetic Resonance Imaging 16%

• Editorial: Genotype–phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures

  Ferraro, P. M., Spotorno, N., Finegan, E., Sampedro, F. & Caso, F., 2022 Dec, In: Frontiers in Neurology. 13, 1100953.

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

• Empirical pathological staging and subtyping of TDP-43 proteinopathies

  Young, A. L., Vogel, J. W., Robinson, J., McMillan, C. T., Ossenkoppele, R., Wolk, D. A., Irwin, D. J., Elman, L., Grossman, M., Lee, V. M. Y., Lee, E. B., Trojanowski, J. Q. & Hansson, O., 2022 Dec, In: Alzheimer's and Dementia. 18, S4, e063390.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • DNA-binding Protein 100%
  • Subtyping 100%
  • Proteinopathy 100%
  • Encephalopathy 100%
  • Frontotemporal Dementia 100%

• Evaluating the DICE method to improve early recognition and treatment of neuropsychiatric symptoms in early Alzheimer’s disease

  Eikelboom, W. S., van den Berg, E., Raso, F. U. S. M., van Bruchem-Visser, R. L., Goudzwaard, J. A., de Jong, F. J., den Heijer, T., Driesen, J. J. M., Vroegindeweij, L. J. H. M., Thomeer, E. C., Hoogers, S. E., Singleton, E. H., van Swieten, J. C., Ossenkoppele, R., Coesmans, M. & Papma, J. M., 2022 Dec, In: Alzheimer's and Dementia. 18, S8, e062292.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Alzheimer's Disease 100%
  • Caregiver 75%
  • Quality of Life 37%
  • Memory 25%
  • Dementia 25%

• Hippocampal subregional thinning related to tau pathology in early stages of Alzheimer’s disease

  Berron, D., Baumeister, H., Diers, K., Reuter, M., Xie, L., Olsson, E., Andersson, F., Wisse, L. E. M., Strandberg, O., Smith, R., Stomrud, E. & Hansson, O., 2022 Dec, In: Alzheimer's and Dementia. 18, S1, e066846.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Alzheimer's Disease 100%
  • Mild Cognitive Impairment 75%
  • Beta Amyloid 75%
  • Positron Emission Tomography 50%
  • In Vivo 25%

• Quantifying AD-related brain amyloid with linearised progression models: model-based vs. data-based.

  Wink, A. M., Shekari, M., Dicks, E., Collij, L. E., Salvadó, G., García, D. V., Gispert, J. D., Tijms, B. M., Alves, I. L., Yaqub, M., Barkhof, F. & AMYPAD Consortium, 2022 Dec, In: Alzheimer's and Dementia. 18, S1, e061452.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Brain 100%
  • Alzheimer's Disease 100%
  • Information 100%
  • Bayesian 100%
  • Protocerebrum 100%

• Tau burden is associated with cross-sectional and longitudinal neurodegeneration in the medial temporal lobe in cognitively normal individuals

  Xie, L., Wisse, L. E. M., Das, S. R., Lyu, X., de Flores, R., Yushkevich, P. A. & Wolk, D. A., 2022 Dec, In: Alzheimer's and Dementia. 18, S1, e067095.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Neurodegeneration 100%
  • Temporal Lobe 100%
  • Magnetic Resonance Imaging 83%
  • Positron Emission Tomography 66%
  • Beta Amyloid 66%

• The mean diffusion propagator model revealed cortical microstructural changes associated with both amyloid-β and tau pathology and astroglial activation

  Spotorno, N., Strandberg, O., Vis, G., Stomrud, E., Nilsson, M. & Hansson, O., 2022 Dec, In: Alzheimer's and Dementia. 18, S1, e064928.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Amyloid 100%
  • Magnetic Resonance Imaging 100%
  • Positron Emission Tomography 85%
  • Alzheimer's Disease 28%
  • Mild Cognitive Impairment 14%

• Editorial: Gene therapy 2.0: Biotechnology for circuit engineering and complex therapeutic approaches

  Quintino, L., Almeida, L. P. D. & Lundberg, C., 2022 Nov 22, In: Frontiers in Bioengineering and Biotechnology. 10, 2 p., 1082883.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

• Serine racemase modulation for improving brain insulin resistance: An Editorial Highlight for “Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid-β oligomers”

  Duarte, J. M. N., 2022 Oct, In: Journal of Neurochemistry. 163, 1, p. 6-7

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Brain 100%
  • Oligomer 100%
  • Insulin 100%
  • Serine 50%
  • Alzheimer's Disease 28%

• A relatively common hypomorphic variant in WARS2 causes monogenic disease

  Ilinca, A., Kafantari, E. & Puschmann, A., 2022 Jan, In: Parkinsonism and Related Disorders. 94, p. 129-131 3 p.

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

• Hunting out the autophagic problem in Huntington disease

  Pircs, K., Barker, R. A. & Jakobsson, J., 2022, In: Autophagy. 18, 12, p. 3031-3032

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  • Huntington's Disease 100%
  • Huntington Chorea 100%
  • Brain 50%
  • Neurodegenerative Disorder 50%
  • Neuron 50%
• 2021

  Reprogramming Stars #4: A Reprogramming Approach for Parkinson's Disease-An Interview with Dr. Malin Parmar

  Parmar, M. & Pereira, C.-F., 2021 Dec 23, In: Cellular Reprogramming. 23, 6, p. 319-325

  Research output: Contribution to journal › Debate/Note/Editorial

• Repairing the Parkinson Brain

  Björklund, A., Bloem, B. R., Brundin, P. & Federoff, H. J., 2021 Sept 22, In: Journal of Parkinson's Disease. 11, s2, p. S123-S125

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

• Reprogramming Stars #2: Reprogramming towards Neural Lineages - An Interview with Dr. Henrik Ahlenius

  Ahlenius, H. & Pereira, C. F., 2021 Aug 23, In: Cellular Reprogramming. 23, 4, p. 200-205 6 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

• Management of Alzheimer's disease takes a leap forward

  Frisoni, G. B. & Hansson, O., 2021 Aug 1, In: The Lancet. Neurology. 20, 8, p. 586-587 2 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

• Editorial: Regeneration and Brain Repair

  Rylander Ottosson, D., Grade, S. & Heuer, A., 2021 May 20, In: Frontiers in Cellular Neuroscience. 15, 687992.

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

• Alzheimer’s disease in primary care: new tools for improved and simplified diagnostics

  Zetterberg, H. & Stomrud, E., 2021, In: Journal of Internal Medicine. 290, 2, p. 477-479

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

• In memoriam for M. Flint Beal

  Gouras, G. K., 2021, In: Journal of Alzheimer's disease : JAD. 83, 1, p. 1-2

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

• Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations

  Eikelboom, W. S., van den Berg, E., Singleton, E. H., Baart, S. J., Coesmans, M., Leeuwis, A. E., Teunissen, C. E., van Berckel, B. N. M., Pijnenburg, Y. A. L., Scheltens, P., van der Flier, W. M., Ossenkoppele, R. & Papma, J. M., 2021, In: Neurology. 97, 13, p. e1276-e1287

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

  • Alzheimer's Disease 100%
  • Dementia 85%
  • Mild Cognitive Impairment 57%
  • Subjective Cognitive Decline 57%
  • Cognition 28%

• Parkinson's Disease and Post–COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum

  Leta, V., Rodríguez-Violante, M., Abundes, A., Rukavina, K., Teo, J. T., Falup-Pecurariu, C., Irincu, L., Rota, S., Bhidayasiri, R., Storch, A., Odin, P., Antonini, A. & Ray Chaudhuri, K., 2021, In: Movement Disorders. 36, 6, p. 1287-1289 3 p.

  Research output: Contribution to journal › Debate/Note/Editorial › peer-review

  Open Access

• Preface

  Ahlenius, H., 2021, In: Methods in Molecular Biology. 2352, p. v-vi

  Research output: Contribution to journal › Debate/Note/Editorial

• Spatial Distribution of Tau and β-Amyloid Pathologies and Their Role in Different Alzheimer Disease Phenotypes

  Palmqvist, S. & Eshaghi, A., 2021, In: Neurology. 96, 5, p. 191-192 2 p.

  Research output: Contribution to journal › Debate/Note/Editorial

• What will the horrible year of 2020 bring to the future of ageing research?

  Iwarsson, S., Aartsen, M. J., Wahrendorf, M. & Kliegel, M., 2021, In: European Journal of Ageing. 18, 1, p. 1-3

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access
• 2020

  Abstracts of the IAPRD XXV World Congress on Parkinson's Disease and Related Disorders, 2020. Congress theme: Diagnosing and treating movement disorders in the era of personalized medicine

  Fujioka, S. & Puschmann, A., 2020 Oct 1, In: Parkinsonism and Related Disorders. 79, S1, p. E1-E2

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

• Do variants in IRF2BPL cause both neurological disorders and keratoconus 8?

  Kafantari, E., Andréasson, S., Säll, T. & Puschmann, A., 2020 Oct, In: Parkinsonism and Related Disorders. 79, p. 138-140 3 p.

  Research output: Contribution to journal › Debate/Note/Editorial

• Myoclonus-dystonia (DYT11, DYT-SGCE) - a channelopathy?

  Wictorin, K. & Puschmann, A., 2020 Mar 2, In: Neurologia i neurochirurgia polska. 54, 1, p. 3-5 3 p.

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

  • Dystonia 100%
  • Myoclonus 100%
  • Myoclonus dystonia 100%
  • Seizure 40%
  • Patient 40%